Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03203382 · ClinicalTrials.gov registry record
Corneal Nerve Structure in Sjogren's
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 100
- Enrollment target
NCT03203382: Completed study, sponsored by University of Pennsylvania.
NCT03203382 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03203382 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Patients who are suspected of or diagnosed with Sjogren's disease will be evaluated for ocular symptoms and corneal nerve morphology. We are specifically interested in the relationship between Vitamin D level and aberrations in the morphology of the corneal nerves.
Primary Outcome
Heidelberg Retina Tomograph with the Rostock Cornea Module
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-04 |
What the finished NCT03203382 record still lists
NCT03203382 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03203382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03203382 about?
NCT03203382 is a clinical study titled "Corneal Nerve Structure in Sjogren's". Patients who are suspected of or diagnosed with Sjogren's disease will be evaluated for ocular symptoms and corneal nerve morphology. We are specifically interested in the relationship between Vitamin D level and aberrations in the morphology of the corneal nerves.
What is the current status of trial NCT03203382?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-09. Estimated completion is 2017-04.
Who is sponsoring clinical trial NCT03203382?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia